Phenol sulfotransferase was isolated in 100,00% supernatant fractions prepared from postmortem samples of human brain. Since phenol sulfotransferase (PST) has been shown to conjugate the amine neurotransmitters in vivo, the abilities of eight different biogenic amines and structurally related compounds to act as substrates for PST were studied. These experiments demonstrate that at a concentration of 20 p~, dopamine (DA) was the best substrate examined and was followed in decreasing order of activity by 3-methoxytyramine (3-MT), tyramine, norepinephrine, 3-methoxy-4hydroxyphenylethyleneglycol, octopamine. 5-hydroxytryptamine, and dihydroxyphenylethyleneglycol. At a substrate concentration of 100 p~ the relative order of activity was altered, so that tyramine became the most rapidly conjugated substrate while the activity of DA and 3-MT relative to the other substrates tested was diminished. This change in substrate affinity with differing substrate concentrations can be explained, at least for DA, by the occurrence of apparent substrate inhibition at concentrations above 25 to 30 FM. Using PST isolated in 1 0 0 , 0 0~ supernatant fractions from human brain, the K , value for DA was found to be 5.0 p~, while the K , value for the sulfate-donor 3'-phosphoadenosine-S'-phosphosulfate was 0.25 p~. The ratio of 3-0-to 4-0-DA-sulfate formed in vitro by human brain PST was found to be about 4: 1. In addition, both the 3-0-and 4-0-esters were found not to be deaminated by human brain mitochondria1 MAO. The relative role of PST with respect to M A 0 and catechol-0-methyltransferase in the degradation of the biogenic amine neurotransmitters in human brain is discussed. K e y words: Sulfotransferase-Dopamine-Catecholamines-Amine metabolism.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.